{"favorite_id": 10279, "calc_type": "", "dosing": false, "full_title_en": "MuLBSTA Score for Viral Pneumonia Mortality", "short_title_en": "MuLBSTA Score", "medium_description_en": "Predicts 90-day mortality in patients with viral pneumonia.", "short_description_en": "Viral pneumonia mortality.", "before_use": "<p>Launched during COVID-19 crisis. Not externally validated.&nbsp;Use with caution. <a href=\"https://www.mdcalc.com/covid-19\" target=\"_blank\">COVID-19 Resource Center</a>.</p>\n<p><strong>Tips for COVID-19:&nbsp;</strong>Use after diagnosis to determine dispo.&nbsp;Specific for Viral PNA and similar inputs as known COVID-19 mortality risk factors, but not externally validated.</p>", "instructions_en": "", "purpose_en": ["Prognosis"], "disease_en": ["Pneumonia", "Respiratory Distress", "COVID-19", "Coronavirus"], "specialty_en": ["Critical Care", "Emergency Medicine", "Hospitalist Medicine", "Infectious Disease", "Internal Medicine", "Pulmonology"], "chief_complaint_en": ["Chest Pain", "Cough", "Fever", "Shortness of Breath"], "system_en": ["Respiratory"], "search_abbreviation_en": ["MuLBSTA Score, MuLBSTA, pneumonia mortality, pneumonia mortality risk, pneumonia, pneumonia risk, viral pneumonia, viral pneumonia mortality, viral pneumonia mortality risk, MuLBSTA pneumonia, MuLBSTA score pneumonia, Coronavirus, Corona virus, COVID, COVID-19, COVID 19, COVID19"], "slug": "mulbsta-score-viral-pneumonia-mortality", "seo": {"meta_description_en": "The MuLBSTA Score predicts 90-day mortality in patients with viral pneumonia.", "keywords_en": "MuLBSTA Score, MuLBSTA, pneumonia mortality, pneumonia mortality risk, pneumonia, pneumonia risk, viral pneumonia, viral pneumonia mortality, viral pneumonia mortality risk, MuLBSTA pneumonia, MuLBSTA score pneumonia, pneumonia death, viral pneumonia death, Coronavirus, Corona virus, COVID, COVID-19, COVID 19, COVID19"}, "content": {"how_to_use": {"use_case_en": "<p>In patients with viral pneumonia, to predict clinical characteristics that affect mortality.</p>", "pearls_pitfalls_en": "<p><span id=\"docs-internal-guid-a7a77f5c-7fff-f09d-cda3-10f2e9cfb8a0\"></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">Designed specifically for viral pneumonia, which may account for up to 29% of CAP (<a href=\"https://thorax.bmj.com/content/63/1/42\" target=\"_blank\">Jennings 2008</a>).</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">Virus-associated pneumonia is defined as lower respiratory infection with a positive PCR for viral antigen.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">This <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901688/\" target=\"_blank\">single-center, retrospective, not-externally-validated design</a> may lead to bias and unknown applicability and generalizability.</p>\n</li>\n<li dir=\"ltr\">If used on COVID-19 PNA patients, keep in mind that age has a much stronger odds ratio for increasing mortality risk in COVID-19 patients than with other viral PNA patients.</li>\n</ul>", "why_use_en": "<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">Predicts risk factors for mortality that may be unique to viral PNA.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">The MuLBSTA score examines a patient population with similar characteristics to those with COVID-19 PNA, and has inputs similar to risk factors for mortality seen in the initial COVID-19 patient cohorts out of China.</p>\n</li>\n</ul>"}, "next_steps": {"advice_en": "<p><span id=\"docs-internal-guid-2f6d7102-7fff-6787-e672-aa41bf7deb72\"></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">Threshold for disposition may change during resource-limited situations such as the current COVID-19 outbreak.&nbsp;</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">Take into consideration that the upper limit of the &ldquo;low risk&rdquo; group as indicated in the <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901688/\" target=\"_blank\">original study</a> still carries a relatively high mortality rate (e.g. 11 points = 12.27% mortality).</p>\n</li>\n</ul>", "management_en": "", "critical_actions_en": "<p>If applying to a patient with potential COVID-19, use this score in conjunction with clinical suspicion and risk factors - particularly advanced age and comorbidities.</p>"}, "about": {"formula_en": "<p>Addition of the selected points:</p>\n<table width=\"399\" height=\"465\">\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><strong>Variable</strong></p>\n</td>\n<td><strong>Points</strong></td>\n</tr>\n<tr>\n<td rowspan=\"2\"><strong>Mu</strong>ltilobe infiltrate</td>\n<td>\n<p>Yes</p>\n</td>\n<td>5</td>\n</tr>\n<tr>\n<td>\n<p>No</p>\n</td>\n<td>0</td>\n</tr>\n<tr>\n<td rowspan=\"2\"><span id=\"docs-internal-guid-aeef8cd1-7fff-d46e-6170-d9f5beee2355\">Absolute <strong>L</strong>ymphocyte count &le;0.8 x 10<sup>9</sup>/L</td>\n<td>\n<p>Yes</p>\n</td>\n<td>4</td>\n</tr>\n<tr>\n<td>\n<p>No</p>\n</td>\n<td>0</td>\n</tr>\n<tr>\n<td rowspan=\"2\"><strong>B</strong>acterial coinfection (detected by sputum or blood culture)</td>\n<td>\n<p>Yes</p>\n</td>\n<td>4</td>\n</tr>\n<tr>\n<td>\n<p>No</p>\n</td>\n<td>0</td>\n</tr>\n<tr>\n<td rowspan=\"3\"><strong>S</strong>moking history</td>\n<td>\n<p>Non smoker</p>\n</td>\n<td>0</td>\n</tr>\n<tr>\n<td>\n<p>Prior smoker</p>\n</td>\n<td>2</td>\n</tr>\n<tr>\n<td>\n<p>Active smoker</p>\n</td>\n<td>3</td>\n</tr>\n<tr>\n<td rowspan=\"2\">History of hyper-<strong>T</strong>ension</td>\n<td>\n<p>Yes</p>\n</td>\n<td>2</td>\n</tr>\n<tr>\n<td>\n<p>No</p>\n</td>\n<td>0</td>\n</tr>\n<tr>\n<td rowspan=\"2\"><strong>A</strong>ge &ge;60 years</td>\n<td>\n<p>Yes</p>\n</td>\n<td>2</td>\n</tr>\n<tr>\n<td>\n<p>No</p>\n</td>\n<td>0</td>\n</tr>\n</tbody>\n</table>", "more_info_en": "<p>Interpretation:</p>\n<table width=\"401\" height=\"246\" style=\"height: 246px;\">\n<tbody>\n<tr>\n<td>\n<p><strong>MuLBSTA Score</strong></p>\n</td>\n<td><strong>90-day mortality</strong></td>\n</tr>\n<tr>\n<td>\n<p>0</p>\n</td>\n<td>0.47%</td>\n</tr>\n<tr>\n<td>\n<p>2</p>\n</td>\n<td>0.87%</td>\n</tr>\n<tr>\n<td>\n<p>3</p>\n</td>\n<td>1.18%</td>\n</tr>\n<tr>\n<td>\n<p>4</p>\n</td>\n<td>1.60%</td>\n</tr>\n<tr>\n<td>\n<p>5</p>\n</td>\n<td>2.17%</td>\n</tr>\n<tr>\n<td>\n<p>6</p>\n</td>\n<td>2.92%</td>\n</tr>\n<tr>\n<td>\n<p>7</p>\n</td>\n<td>3.93%</td>\n</tr>\n<tr>\n<td>\n<p>8</p>\n</td>\n<td>5.27%</td>\n</tr>\n<tr>\n<td>\n<p>9</p>\n</td>\n<td>7.03%</td>\n</tr>\n<tr>\n<td>\n<p>10</p>\n</td>\n<td>9.33%</td>\n</tr>\n<tr>\n<td>\n<p>11</p>\n</td>\n<td>12.27%</td>\n</tr>\n<tr>\n<td>\n<p>12</p>\n</td>\n<td>15.99%</td>\n</tr>\n<tr>\n<td>\n<p>13</p>\n</td>\n<td>20.56%</td>\n</tr>\n<tr>\n<td>\n<p>14</p>\n</td>\n<td>26.03%</td>\n</tr>\n<tr>\n<td>\n<p>15</p>\n</td>\n<td>32.36%</td>\n</tr>\n<tr>\n<td>\n<p>16</p>\n</td>\n<td>39.42%</td>\n</tr>\n<tr>\n<td>\n<p>17</p>\n</td>\n<td>46.95%</td>\n</tr>\n<tr>\n<td>\n<p>18</p>\n</td>\n<td>54.61%</td>\n</tr>\n<tr>\n<td>\n<p>19</p>\n</td>\n<td>62.07%</td>\n</tr>\n<tr>\n<td>\n<p>20</p>\n</td>\n<td>68.99%</td>\n</tr>\n</tbody>\n</table>", "evidence_based_medicine_en": "<p><span id=\"docs-internal-guid-d402546d-7fff-823d-9397-ce73a32dda5f\">Based on a <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901688/\" target=\"_blank\">single-center&nbsp;study</a> in China. Enrolled 528 patients between May 2015 and May 2019. Retrospectively analyzed all patients with positive viral PCR samples for respiratory illness and included those who had radiologic evidence of pneumonia in analysis.</p>", "references_list": {"Original/Primary Reference": [{"href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901688/", "text": "Guo L, Wei D, Zhang X, et al. Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score. Front Microbiol. 2019;10:2752."}], "Other References": [{"href": "https://thorax.bmj.com/content/63/1/42", "text": "Jennings LC, Anderson TP, Beynon KA, et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax. 2008;63(1):42-8."}], "Validation": [], "Clinical Practice Guidelines": [], "Manufacturer Website": [], "Outcomes": []}}, "contributor": {"expert_name": [{"description": "<p>Joseph Habboushe, MD, MBA, is a practicing emergency physician and assistant professor at New York University Langone Medical Center and Bellevue Medical Centers in New York City. He is the CEO and co-founder of MDCalc. Dr. Habboushe is also the creator and editor-in-chief of the pocket guide series, <em><a href='https://www.amazon.com/Basics-Emergency-Medicine-Chief-Complaint/dp/B00558UQSS/ref=la_B00588L7A6_1_1?s=books&ie=UTF8&qid=1470671240&sr=1-1' target='_blank'>The Basics of Emergency Medicine</a></em>, published by the Emergency Medicine Residents' Association.</p>", "firstName": "Joseph", "img": "https://cdn-web-img.mdcalc.com/people/joe-habboushe.jpeg", "lastName": "Habboushe", "name": "Joseph Habboushe, MD, MBA", "target": "joseph-habboushe", "signedCOI": true, "hasDisclosure": []}, {"description": "", "firstName": "Eric", "img": "https://cdn-web-img.mdcalc.com/people/eric-steinberg.jpg", "lastName": "Steinberg", "name": "Eric Steinberg, DO", "target": "eric-steinberg", "signedCOI": false, "hasDisclosure": []}]}, "creator": [{"name": "Dr. Xinxin Zhang", "qa_en": "", "approved": false, "creator_info": {"about_en": "<p>Xinxin Zhang, MD, PhD, is a professor of infectious diseases at Shanghai Jiao Tong University in China. She is also vice chairman of the Shanghai Hepatology Society and has published over 160 papers, with contributions to journals like <i>Gut</i> and the <i>Journal of Clinical Microbiology</i>. Dr. Zhang\u2019s primary research is focused on the pathology and treatment of various infectious diseases such as hepatitis and viral pneumonia.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-Zhang-Xinxin.png", "pubmedLink": "https://pubmed.ncbi.nlm.nih.gov/?term=Zhang+X&cauthor_id=31849894"}}], "reviewer": {"expert_name": []}, "related_resources": {"mdcalc_rating": [], "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "toggle", "label_en": "<strong>Mu</strong>ltilobe infiltrate", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 5}], "name": "one"}, {"type": "toggle", "label_en": "Absolute <strong>L</strong>ymphocyte count \u22640.8 x 10<sup>9</sup>/L", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 4}], "name": "two"}, {"type": "toggle", "label_en": "<strong>B</strong>acterial coinfection", "default": 0, "conditionality": "", "show_points": true, "tips_en": "Detected by sputum or blood culture", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 4}], "name": "three"}, {"type": "radio", "label_en": "<strong>S</strong>moking history", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "Non smoker", "value": 0}, {"label": "Prior smoker", "value": 2}, {"label": "Active smoker", "value": 3}], "name": "four"}, {"type": "toggle", "label_en": "History of hyper-<strong>T</strong>ension", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 2}], "name": "six"}, {"type": "toggle", "label_en": "<strong>A</strong>ge \u226560 years", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 2}], "name": "seven"}], "md5": "", "cmeReleaseDate": null, "cmeEndDate": null, "cmeLastReviewed": null, "related_calcs": [{"calcId": 10280, "short_title_en": "SCAP Score", "slug": "severe-community-acquired-pneumonia-scap-score"}, {"calcId": 10371, "short_title_en": "CIRC", "slug": "covid-19-inpatient-risk-calculator-circ"}, {"calcId": 10354, "short_title_en": "CHOSEN Risk Score", "slug": "covid-home-safely-now-chosen-risk-score-covid-19"}]}